scispace - formally typeset
G

Guanghui Ma

Researcher at Chinese Academy of Sciences

Publications -  519
Citations -  21012

Guanghui Ma is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Membrane emulsification & Antigen. The author has an hindex of 66, co-authored 497 publications receiving 17108 citations. Previous affiliations of Guanghui Ma include Center for Advanced Materials & Nanjing Tech University.

Papers
More filters
Journal ArticleDOI

Superior Intratumoral Penetration of Paclitaxel Nanodots Strengthens Tumor Restriction and Metastasis Prevention

TL;DR: The successful preparation of nanocrystallites of insoluble chemotherapeutic drug paclitaxel (PTX) in forms of nanodots (NDs) and nanoparticles (NPs) with considerably high drug loading capacity is reported, revealing the significant influence of particle size variation in nanoscale.
Journal ArticleDOI

Synthesis of uniform microspheres with higher content of 2‐hydroxyethyl methacrylate by employing SPG (Shirasu porous glass) emulsification technique followed by swelling process of droplets

TL;DR: In this article, uniform microspheres containing a hydrophilic monomer, 2-hy- droxyethyl methacrylate (HEMA), were prepared by employing a swelling method of uniform seed droplets.
Journal ArticleDOI

A novel strategy for the preparation of porous microspheres and its application in peptide drug loading.

TL;DR: It is suggested that it is potential to construct porous microspheres for drug sustained release using permanent geometric templates as new porogens following a fabrication of porousmicrospheres without any porogens followed by a pore closing process.
Journal ArticleDOI

Preparation and characterization of thermo-responsive albumin nanospheres

TL;DR: The design of PAN overcame the disadvantages of temperature-responsive polymeric micelles, and the biodegradable AN was attacked more easily by trypsin.
Journal ArticleDOI

Exploration of Antigen Induced CaCO3 Nanoparticles for Therapeutic Vaccine.

TL;DR: A biomimetic strategy is developed to fabricate hierarchical ovalbumin@CaCO3 nanoparticles (OVA@NP) under the templating effect of antigen OVA that cooperatively promote antigen cross-presentation, elicit CD8 T cell proliferation, ignite a potent and specific CTL response, and finally achieve prominent tumor therapy effects.